Document is current
Any future updates will be listed below
-
Authors
Lenk, Lennart
Carlet, Michela
Vogiatzi, Fotini
Spory, Lea
Winterberg, Dorothee
Cousins, Antony https://orcid.org/0000-0003-1516-2515
Vossen-Gajcy, Michaela
Ibruli, Olta
Vokuhl, Christian
Cario, Gunnar
El Ayoubi, Omar
Kramer, Lisa
Ritgen, Matthias
Brüggemann, Monika
Häsler, Robert
Schrappe, Martin
Fuhrmann, Stephan https://orcid.org/0000-0002-7785-2565
Halsey, Christina https://orcid.org/0000-0001-5449-5246
Jeremias, Irmela https://orcid.org/0000-0003-1773-7677
Hobeika, Elias
Jumaa, Hassan https://orcid.org/0000-0003-3383-141X
Alsadeq, Ameera https://orcid.org/0000-0003-0568-9890
Schewe, Denis M. https://orcid.org/0000-0002-1070-0217
- License Information
-
More Information
Article History
Received: 30 June 2020
Accepted: 25 November 2020
First Online: 15 January 2021
Competing interests
: The authors declare the following competing interests: M.B. received consulting fees from PRMA, research funding from Amgen, honoraria from Novartis, Pfizer, and Amgen and was an advisory board member for Incyte and Amgen. D.M.S. was an advisory board member for Bayer, SOBI and Jazz Pharmaceuticals and received research funding from OSE Pharmaceuticals. M.S. received research funding from Shire, and from Servier, as well as fees for Advisory Board functions from Jazzpharma, and Servier. The other authors declare no competing interests.
